lisinopril and hydrochlorothiazide
Generic: lisinopril and hydrochlorothiazide
Labeler: northwind health company, llcDrug Facts
Product Profile
Brand Name
lisinopril and hydrochlorothiazide
Generic Name
lisinopril and hydrochlorothiazide
Labeler
northwind health company, llc
Dosage Form
TABLET
Routes
Active Ingredients
hydrochlorothiazide 12.5 mg/1, lisinopril 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51655-414
Product ID
51655-414_48ff1546-2be0-f86d-e063-6394a90a1fe4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076194
Listing Expiration
2027-12-31
Marketing Start
2014-08-25
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51655414
Hyphenated Format
51655-414
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisinopril and hydrochlorothiazide (source: ndc)
Generic Name
lisinopril and hydrochlorothiazide (source: ndc)
Application Number
ANDA076194 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 20 mg/1
Packaging
- 90 TABLET in 1 BOTTLE, PLASTIC (51655-414-26)
- 30 TABLET in 1 BOTTLE, DISPENSING (51655-414-30)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48ff1546-2be0-f86d-e063-6394a90a1fe4", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197886"], "spl_set_id": ["3d801e51-e675-45eb-bc7e-407e610f4009"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (51655-414-26)", "package_ndc": "51655-414-26", "marketing_start_date": "20210629"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, DISPENSING (51655-414-30)", "package_ndc": "51655-414-30", "marketing_start_date": "20140825"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "51655-414_48ff1546-2be0-f86d-e063-6394a90a1fe4", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "51655-414", "generic_name": "Lisinopril and Hydrochlorothiazide", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA076194", "marketing_category": "ANDA", "marketing_start_date": "20140825", "listing_expiration_date": "20271231"}